14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.61 $5.84 Friday, 3rd May 2024 AUTL stock ended at $4.19. This is 1.95% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.52% from a day low at $4.06 to a day high of $4.36.
90 days $3.61 $7.37
52 weeks $1.79 $7.45

Historical Autolus Therapeutics plc prices

Date Open High Low Close Volume
May 03, 2024 $4.22 $4.36 $4.06 $4.19 1 943 611
May 02, 2024 $4.03 $4.20 $3.96 $4.11 1 757 632
May 01, 2024 $3.68 $4.17 $3.63 $4.00 7 722 724
Apr 30, 2024 $3.74 $3.87 $3.61 $3.68 3 561 662
Apr 29, 2024 $4.00 $4.14 $3.79 $3.80 5 152 750
Apr 26, 2024 $4.09 $4.15 $3.99 $4.00 2 739 098
Apr 25, 2024 $4.18 $4.29 $3.96 $4.08 3 872 781
Apr 24, 2024 $4.52 $4.60 $4.15 $4.21 2 720 768
Apr 23, 2024 $4.58 $4.71 $4.48 $4.48 1 723 639
Apr 22, 2024 $4.50 $4.65 $4.48 $4.56 1 144 187
Apr 19, 2024 $4.75 $4.84 $4.49 $4.52 1 402 269
Apr 18, 2024 $5.14 $5.25 $4.79 $4.80 1 191 109
Apr 17, 2024 $4.97 $5.05 $4.83 $4.84 757 493
Apr 16, 2024 $4.90 $5.00 $4.84 $4.86 599 081
Apr 15, 2024 $5.00 $5.18 $4.86 $4.90 786 132
Apr 12, 2024 $5.21 $5.34 $4.98 $5.02 1 487 840
Apr 11, 2024 $5.17 $5.41 $5.17 $5.33 778 660
Apr 10, 2024 $5.43 $5.43 $5.15 $5.15 905 620
Apr 09, 2024 $5.54 $5.54 $5.29 $5.43 486 194
Apr 08, 2024 $5.67 $5.67 $5.26 $5.43 1 490 891
Apr 05, 2024 $5.45 $5.70 $5.37 $5.60 700 335
Apr 04, 2024 $5.54 $5.84 $5.45 $5.51 681 506
Apr 03, 2024 $5.47 $5.67 $5.40 $5.49 875 014
Apr 02, 2024 $5.65 $5.84 $5.48 $5.51 1 035 465
Apr 01, 2024 $6.27 $6.31 $5.58 $5.68 2 400 383
Click to get the best stock tips daily for free!

About Autolus Therapeutics plc

Autolus Therapeutics plc Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a program... AUTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT